Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2/3 Treatment of Anxiety in Autism Spectrum Disorder

NCT02028247 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT02028247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2/3 Treatment of Anxiety in Autism Spectrum Disorder
Lead sponsor
University of South Florida
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
October 31, 2018
Enrollment
214 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asperger's syndrome, autism, autism spectrum disorders, generalized anxiety disorder, obsessive-compulsive disorder, pervasive developmental disability - not otherwise specified, separation anxiety disorder, social phobia, specific phobia